MORETTI, Rita
 Distribuzione geografica
Continente #
NA - Nord America 24.199
EU - Europa 22.050
AS - Asia 11.066
SA - Sud America 1.678
AF - Africa 337
OC - Oceania 84
Continente sconosciuto - Info sul continente non disponibili 20
Totale 59.434
Nazione #
US - Stati Uniti d'America 23.769
IT - Italia 10.408
SG - Singapore 3.917
PL - Polonia 3.793
CN - Cina 2.234
UA - Ucraina 1.951
BR - Brasile 1.298
HK - Hong Kong 1.178
VN - Vietnam 1.170
SE - Svezia 1.152
NL - Olanda 887
KR - Corea 876
FR - Francia 702
FI - Finlandia 661
TR - Turchia 518
DE - Germania 496
RU - Federazione Russa 409
GB - Regno Unito 406
IE - Irlanda 369
BG - Bulgaria 344
CA - Canada 291
IN - India 289
BD - Bangladesh 204
AR - Argentina 142
JP - Giappone 121
MA - Marocco 98
ID - Indonesia 79
MX - Messico 76
AU - Australia 74
CH - Svizzera 71
EC - Ecuador 70
IQ - Iraq 70
ES - Italia 65
PK - Pakistan 63
IR - Iran 62
ZA - Sudafrica 62
SN - Senegal 48
CO - Colombia 46
BE - Belgio 41
AT - Austria 40
EG - Egitto 39
CZ - Repubblica Ceca 35
CL - Cile 32
RO - Romania 31
SA - Arabia Saudita 31
TN - Tunisia 30
VE - Venezuela 27
IL - Israele 26
DK - Danimarca 25
PT - Portogallo 25
AE - Emirati Arabi Uniti 24
DZ - Algeria 24
PY - Paraguay 23
JO - Giordania 20
TW - Taiwan 20
UZ - Uzbekistan 19
MY - Malesia 17
PH - Filippine 17
KE - Kenya 16
UY - Uruguay 16
LT - Lituania 15
KZ - Kazakistan 14
PE - Perù 14
RS - Serbia 14
GR - Grecia 13
LB - Libano 13
SI - Slovenia 13
TH - Thailandia 13
HU - Ungheria 12
JM - Giamaica 12
NO - Norvegia 12
SK - Slovacchia (Repubblica Slovacca) 12
CR - Costa Rica 11
EU - Europa 11
PS - Palestinian Territory 11
NZ - Nuova Zelanda 10
BO - Bolivia 9
BY - Bielorussia 9
NG - Nigeria 9
OM - Oman 9
AL - Albania 8
AZ - Azerbaigian 8
GE - Georgia 8
HR - Croazia 8
TT - Trinidad e Tobago 8
GT - Guatemala 7
LV - Lettonia 6
PA - Panama 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
HN - Honduras 5
MD - Moldavia 5
NP - Nepal 5
CY - Cipro 4
DO - Repubblica Dominicana 4
EE - Estonia 4
LU - Lussemburgo 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
BS - Bahamas 3
Totale 59.393
Città #
Warsaw 3.452
Woodbridge 2.807
Singapore 2.292
Ann Arbor 2.150
Houston 2.082
Fairfield 1.730
Ashburn 1.727
Jacksonville 1.646
Chandler 1.141
Hong Kong 1.135
Wilmington 1.054
San Jose 891
Seoul 846
Seattle 735
Hefei 661
Milan 656
Princeton 635
Cambridge 596
Chicago 545
Beijing 506
Rome 501
Boardman 499
Trieste 385
Izmir 366
Ho Chi Minh City 354
Dublin 349
Columbus 340
Sofia 336
Zgierz 305
Lauterbourg 290
Los Angeles 282
Hanoi 238
Moscow 233
Buffalo 187
The Dalles 186
Toronto 184
Santa Clara 159
Dallas 154
Naples 141
Dearborn 126
New York 121
San Diego 120
Council Bluffs 118
Redwood City 111
Bologna 109
São Paulo 109
Verona 108
Düsseldorf 105
Helsinki 99
London 97
Florence 87
Frankfurt am Main 82
Turin 82
Bari 81
Palermo 79
Casablanca 75
Salt Lake City 73
Dong Ket 64
Genoa 61
Orem 57
Catania 55
Phoenix 55
Amsterdam 52
Guangzhou 52
Tokyo 52
Brescia 50
Haiphong 50
Da Nang 48
Dakar 48
Hamburg 46
Shanghai 46
Redmond 44
Padova 43
Nanjing 41
Rio de Janeiro 40
Washington 40
Cagliari 38
Munich 38
Falls Church 37
Venezia 37
Nuremberg 36
Torino 36
Brooklyn 35
Atlanta 33
Elk Grove Village 33
Kunming 33
Norwalk 33
Tianjin 32
Pescara 31
Chennai 30
Modena 30
Montreal 30
Redondo Beach 30
Sacile 30
Brussels 29
Johannesburg 29
Parma 29
Tampa 29
Curitiba 28
Mumbai 28
Totale 36.276
Nome #
Danni cerebrali post-attinici 8.751
Valutazione neuropsicologica di quattro casi di encefalopatia post-attinica. 675
Bilirubin and inflammation in neurodegenerative and other neurological diseases 634
Focus on Neuro Behcet's disease: a review 612
An iatrogenic model of brain small-vessel disease: Post-radiation encephalopathy 546
Wernicke Korsakoff Encephalopathy 513
Subcortical vascular damages for post radiation brain radiotherapy 457
Brain Cytochrome p450 enzymes: a possible Therapeutic Targets for Neurological Diseases 455
Speech disorder and behavioral involvement in a thalamic stroke: a case report 439
The controversial role of homocysteine in neurology: From labs to clinical practice 429
Complex neurological symptoms in bilateral thalamic stroke due to Percheron artery occlusion 425
Basal ganglia: Their role in complex cognitive procedures in experimental models and in clinical practice 413
Hepatitis C-related cryoglobulinemic neuropathy: Potential role of oxcarbazepine for pain control 384
What does Doppler Ultrasonography Brings to the Diagnosis of Traumatic Vertebral Artery Dissection 381
Cortical modulation of pupillary function: Systematic review 348
Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease 338
Earliest mechanisms of dopaminergic neurons sufferance in a novel slow progressing ex vivo model of parkinson disease in rat organotypic cultures of substantia nigra 324
null 319
null 312
Anatomy of Basal Ganglia and Thalamus 299
Management of restless legs syndrome in chronic liver disease: a challenge for the correct diagnosis and therapy 294
Thiamine and alcohol for brain pathology: super-imposing or different causative factors for brain damage? 284
Akinetic-rigid and tremor-dominant parkinson's disease: Two distinct cognitive and behavioral evolutions 283
The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases 279
Small vessel disease to subcortical dementia: A dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit 278
Vitamin D in neurological disease: a rationale for a pathogenic impact 272
null 266
B vitamins and fatty acids: What do they share with small vessel disease-related dementia? 260
Apathy in corticobasal degeneration: possible parietal involvement 256
Thalamus and language: What do we know from vascular and degenerative pathologies 250
Cerebral hemodynamic changes during motor imagery and passive robot-assisted movement of the lower limbs 248
Non-alcoholic fatty liver disease and neurological defects 246
From brain to heart: Possible role of amyloid-β in ischemic heart disease and ischemia-reperfusion injury 246
Olfactory loss in Multiple Sclerosis 241
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 241
Homocysteine in neurology: From endothelium to Neurodegeneration 238
Bilingual aphasia and subcortical-cortical lesions. 234
Depressione vascolare e demenza vascolare sottocorticale. 229
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 228
A 12 MONTH FOLLOW-UP IN FIFTEEN PATIENTS WITH PARKINSON’ DISEASE: NEUROPSYCHOLOGICAL CHANGES AFTER SUBTHALAMIC NUCLEUS STIMULATION. 226
Depression and Alzheimer's disease: Symptom or comorbidity? 221
An f-MRI evaluation of cerebrocortical activation during learned motor performance. 219
Sexual dysfunction in multiple sderosis: a case-control study. 1. Frequency and comparison of groups 217
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis 216
Freezing in on: significato funzionale di un sintomo o di una sindrome. 216
Visual impairments and attention in parkinson's disease 206
Is Parkinson's disease an unique clinical entity? Rigid or tremor dominant PD: Two faces of the same coin 199
Agraphia in early stage of Alzheimer’s Disease: , a correlation analysis with cognitive performances. 198
A brainstem angioma: consideration on a single case. 198
Small vessel disease-related dementia: An invalid neurovascular coupling? 195
An Open-Label Pilot Study Comparing Rivastigmine and Low-Dose Aspirin for the Treatment of Symptoms Specific to Patients with Subcortical Vascular Dementia 194
Writing errors by normal subjects. 194
Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms 194
Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality 191
Gait and Apathy as Relevant Symptoms of Subcortical Vascular Dementia 191
Vitamin D in the Brain Small Vessel Disease 185
Ten-point clock test: a correlation analysis with other neuropsychological tests in dementia 183
BEHAVIORAL ALTERATIONS AND VASCULAR DEMENTIA 182
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease 182
Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients 181
Apathy: A Complex Symptom Specific to the Clinical Pattern of Presentation of Parkinson’s Disease? 181
Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: A 24-month follow-up of 68 patients 180
Gabapentin for the Treatment of Behavioural Alterations in Dementia 179
NEUROPSYCHOLOGICAL EVALUATION OF LATE ONSET POST-RADIOTHERAPY ENCEPHALOPATHY: A COMPARISON WITH VASCULAR DEMENTIA. 179
Deep brain stimulation of the subthalamus: Neuropsychological effects 179
A Comparison with writing alteration in AD. 178
Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation. 177
Rivastigmine and Parkinson dementia complex. 176
A NEUROPSYCHOLOGICAL COMPARISON BETWEEN SUBCORTICAL VASCULAR DEMENTIA AND FRONTAL LOBE DEMENTIA. 176
Ten-Point Clock Test: a correlation analysis with mini-mental state and proverb interpretation score in Alzheimer's disease 176
Sexual dysfunction in Multiple Sclerosis. A case control study. Frequency and comparison of groups 173
Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients 173
A reduction of freezing of thoughts and of interference mistakes as a consequence of DBS-STN. 173
ACUTE ISCHEMIC STROKE MANAGEMENT: THE STATE OF THE ART HOT TOPICS IN NEUROLOGY AND PSYCHIATRY, ISSUE 6 171
ALZHEIMER’S DEMENTIA AND VASCULAR RISK FACTORS. 169
Gabapentin treatment of glossopharyngeal neuralgia: a follow-up of four years of a single case 169
Apathy as a Key Symptom in Behavior Disorders: Difference Between Alzheimer’s Disease and Subcortical Vascular Dementia 168
Subcortical vascular dementia 167
Corticobasal degeneration: Structural and functional MRI and single-photon emission computed tomography 166
Risk factors for vascular dementia: hypotension as a key point. 166
Cortical-basal ganglionic degeneration: a clinical, functional and cognitive evaluation (1-year follow-up) 166
An open, 16-month, comparative study on rivastigmine in subcortical vascular dementia 164
An f-MRI evaluation of motor skills in corticobasal degeneration 164
Dementia evaluation tests at the patient’s bedside: A neurological-internal approach. 162
Treatment of chronic hiccups: new perspectives 161
eFFETTO DELLA DOXAZOSINA SUI FATTORI DI RISCHIO CARDIOVASCOLARE E SULLA FUNZIONE NERVOSA PERIFERICA IN PAZIENTI IPERTESI E DIABETICI: FOLLOW-UP A 12 MESI. 160
Different responses to rivastigmine in Subcortical vascular dementia and multi- infarct dementia 159
null 159
Fronto-temporal dementia versus Alzheimer disease 159
Alzheimer or Something Else? Corticobasal Degeneration Presenting as Dementia Phenotpye 158
Peculiar Aspects of Reading and Writing Performances in Patients with Olivopontocerebellar Atrophy 158
Alzeheimer or something else? Corticobasal degeneration presenting as dementia-phenotype 157
Cognitive changes following subthalamic nucleus stimulation in two Patients with Parkinson disease. 157
Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up 157
Common Shared Pathogenic Aspects of Small Vessels in Heart and Brain Disease 157
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. II. CORRELATION ANALYSIS 156
Memantine: reality and potentiality. 156
A neuropsychological evaluation of freezing in on 156
Alterazioni cognitive e funzionali nel follow-up di Pazienti con degenerazione corticobasale 155
DIFFICULTIES IN THE MANAGEMENT OF FRONTAL DEMENTIA: THERAPEUTICS STRATEGIES. 155
Totale 32.767
Categoria #
all - tutte 156.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021422 0 0 0 0 0 0 0 0 0 0 0 422
2021/20223.761 142 318 364 367 90 197 126 195 499 478 285 700
2022/20235.424 552 505 355 544 557 894 132 409 598 182 426 270
2023/20244.170 253 294 314 283 383 371 494 717 58 211 371 421
2024/20258.181 493 418 598 803 760 703 591 614 1.083 774 587 757
2025/202615.109 1.613 829 1.389 1.763 1.174 1.461 1.789 638 1.540 1.945 585 383
Totale 60.190